hypoxanthine and AIDS Seroconversion

hypoxanthine has been researched along with AIDS Seroconversion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Foga, IO; Geiger, JD; Hasinoff, BB; Nath, A	1

Other Studies

1 other study(ies) available for hypoxanthine and AIDS Seroconversion

Article	Year
Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Dec-01, Volume: 16, Issue:4 Topics: Anti-HIV Agents; Antioxidants; Dipyridamole; Dose-Response Relationship, Drug; HIV Antibodies; HIV Envelope Protein gp120; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Hypoxanthine; Monocytes; Oxidative Stress; Reactive Oxygen Species; Tumor Cells, Cultured; Xanthine	1997

Article

Year

Antioxidants and dipyridamole inhibit HIV-1 gp120-induced free radical-based oxidative damage to human monocytoid cells.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1997, Dec-01, Volume: 16, Issue:4

Topics: Anti-HIV Agents; Antioxidants; Dipyridamole; Dose-Response Relationship, Drug; HIV Antibodies; HIV Envelope Protein gp120; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Hypoxanthine; Monocytes; Oxidative Stress; Reactive Oxygen Species; Tumor Cells, Cultured; Xanthine

1997